Status:
COMPLETED
Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial
Lead Sponsor:
GWT-TUD GmbH
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
40-70 years
Phase:
PHASE3
Brief Summary
The aim of the study was to analyse the independent and joint effects of the components of the metabolic syndrome (MetS) on the incidence of diabetes in people with impaired glucose tolerance (IGT) an...
Eligibility Criteria
Inclusion
- High risk population
- Age 40 to 70 yrs.
- BMI \> 25 and \< 40; FPG \>5.5 mmol/l and \< 7.8 mmol/l; IGT in OGGT
Exclusion
- Known type 2 diabetes
- Drug intake affecting glucose tolerance
- Any cardiovascular events within the last 6 months
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
1429 Patients enrolled
Trial Details
Trial ID
NCT00629213
Last Update
March 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GWT-TUD GmbH
Dresden, Saxony, Germany, 01187